Проект клинических рекомендаций РОН Тактика ведения доношенных и недоношенных новорожденных детей с непрямой гипербилирубинемией 24.10.201646
Российское общество неонатологов113.
Eidelman Al, Schimmel MS, Algur N, et al. Capillary and venous bilirubin values: they are different—and how! Am J Dis Child 1989;143:642.
114.
Glader B, Allen GA. Neonatal hemolysis. In: de Alarcon PA, Werner EJ,
Christensen RD, eds. Neonatal hematology, pathogenesis, diagnosis, and management of hematologic problems, 2nd ed. Cambridge UK: Cambridge University Press, 2013:91.
115.
Herschel M, Karrison T, Wen M, et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-lncompatible but direct antiglobulin testnegative neonates.
Pediatrics 2002; 110:127.
116.
Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 2006; 118:276.
117.
Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001; 108:31.
118.
Mehta S, Kumar P, Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr
2005;147:781.
119.
Boo NY, Lee H-T. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinemia. J Paediatr Child Health 2002;38:151.
120.
M. Jeffrey Maisels, M.B., B.Ch., and Antony F. McDonagh, Ph.D. Phototherapy for Neonatal Jaundice. N Engl J Med 2008;358:920-8.
121.
Maisels MJ, Newman ТВ. Phototherapy and other treatments. In: Stevenson DK,
Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw Hill,
2012:195.
122.
Newman ТВ, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006;354:1889.
123.
Steiner LA, Bizzarro MJ, Ehrenkranz RA, etal.A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120:27.
124.
Bhutani VK; Committee on Fetus and Newborn. Technical report: phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011; 128:e1046.
125.
Maisels MJ, Kring EA, DeRidder J. Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 2007;27:565.
126.
Subcommittee on hyperbilirubinaemia, American Academy of Pediatrics.
Management ofhyperbilirubinaemia in the newborn infant 35 or more weeks of gestation,
Clinical Practice Guideline. Pediatrics 2004, 114(1): 297-316.
127.
Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol
2012;32:660.
128.
Clinical practice guidline : Management of Hyperbilirubinemia in the Newborn
Infant > 35 weeks of gestation Pediatrics 2004(July); 114:297 129.
Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF, eds. Neonatal jaundice. London, UK:
Harwood Academic Publishers, 2000:169 130.
Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114:e 130.
131.
Rubaltelli FF, Zanardo V, Granati B. Effectofvarious phototherapy regimens on bilirubin decrement. Pediatrics 1978;61:838.